company background image
EQS logo

Equasens Société anonyme ENXTPA:EQS Rapporto sulle azioni

Ultimo prezzo

€41.80

Cap. di mercato

€628.3m

7D

-8.2%

1Y

-28.3%

Aggiornato

18 Nov, 2024

Dati

Dati finanziari dell'azienda +

Equasens Société anonyme

ENXTPA:EQS Rapporto sulle azioni

Cap. di mercato: €628.3m

EQS Panoramica delle azioni

Equasens Société anonyme fornisce soluzioni informatiche per la sanità in Europa. Maggiori dettagli

EQS analisi fondamentale
Punteggio fiocco di neve
Valutazione5/6
Crescita futura2/6
Prestazioni passate2/6
Salute finanziaria6/6
Dividendi5/6

Equasens Société anonyme Concorrenti

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Equasens Société anonyme
Prezzi storici delle azioni
Prezzo attuale dell'azione€41.80
Massimo di 52 settimane€67.40
Minimo di 52 settimane€41.30
Beta0.89
1Variazione di 1 mese-18.99%
Variazione a 3 mesi-8.83%
Variazione di 1 anno-28.30%
3Variazione a 3 anni-52.98%
Variazione a 5 anni-27.05%
Variazione dall'IPO881.22%

Notizie e aggiornamenti recenti

Recent updates

The Equasens Société anonyme (EPA:EQS) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Oct 03
The Equasens Société anonyme (EPA:EQS) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?

Sep 28
Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?

Equasens Société anonyme's (EPA:EQS) Intrinsic Value Is Potentially 75% Above Its Share Price

Jul 15
Equasens Société anonyme's (EPA:EQS) Intrinsic Value Is Potentially 75% Above Its Share Price

Equasens Société anonyme's (EPA:EQS) Upcoming Dividend Will Be Larger Than Last Year's

Jun 22
Equasens Société anonyme's (EPA:EQS) Upcoming Dividend Will Be Larger Than Last Year's

Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?

Jun 07
Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?

Equasens Société anonyme (EPA:EQS) Is Aiming To Keep Up Its Impressive Returns

Apr 03
Equasens Société anonyme (EPA:EQS) Is Aiming To Keep Up Its Impressive Returns

At €51.10, Is It Time To Put Equasens Société anonyme (EPA:EQS) On Your Watch List?

Mar 08
At €51.10, Is It Time To Put Equasens Société anonyme (EPA:EQS) On Your Watch List?

Some Confidence Is Lacking In Equasens Société anonyme's (EPA:EQS) P/E

Feb 14
Some Confidence Is Lacking In Equasens Société anonyme's (EPA:EQS) P/E

Estimating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)

Jan 27
Estimating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)

Should You Investigate Equasens Société anonyme (EPA:EQS) At €59.70?

Nov 29
Should You Investigate Equasens Société anonyme (EPA:EQS) At €59.70?

These 4 Measures Indicate That Equasens Société anonyme (EPA:EQS) Is Using Debt Safely

Oct 28
These 4 Measures Indicate That Equasens Société anonyme (EPA:EQS) Is Using Debt Safely

A Look At The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)

Sep 27
A Look At The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)

Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?

Aug 05
Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?

Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.15

Jun 11
Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.15

Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year

May 22
Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year

Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year

May 08
Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year

What Does Equasens Société anonyme's (EPA:EQS) Share Price Indicate?

Apr 04
What Does Equasens Société anonyme's (EPA:EQS) Share Price Indicate?

Equasens Société anonyme (EPA:EQS) Will Want To Turn Around Its Return Trends

Feb 13
Equasens Société anonyme (EPA:EQS) Will Want To Turn Around Its Return Trends

Calculating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)

Jan 26
Calculating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)

At €71.60, Is Equasens Société anonyme (EPA:EQS) Worth Looking At Closely?

Dec 21
At €71.60, Is Equasens Société anonyme (EPA:EQS) Worth Looking At Closely?

Should You Be Adding Equasens Société anonyme (EPA:EQS) To Your Watchlist Today?

Dec 07
Should You Be Adding Equasens Société anonyme (EPA:EQS) To Your Watchlist Today?

Here's What's Concerning About Equasens Société anonyme's (EPA:EQS) Returns On Capital

Nov 12
Here's What's Concerning About Equasens Société anonyme's (EPA:EQS) Returns On Capital

Is Equasens Société anonyme (EPA:EQS) Trading At A 26% Discount?

Oct 27
Is Equasens Société anonyme (EPA:EQS) Trading At A 26% Discount?

Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?

Oct 12
Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?

When Should You Buy Equasens Société anonyme (EPA:EQS)?

Sep 09
When Should You Buy Equasens Société anonyme (EPA:EQS)?

With EPS Growth And More, Equasens Société anonyme (EPA:EQS) Makes An Interesting Case

Aug 24
With EPS Growth And More, Equasens Société anonyme (EPA:EQS) Makes An Interesting Case

Equasens Société anonyme (EPA:EQS) Might Be Having Difficulty Using Its Capital Effectively

Jul 28
Equasens Société anonyme (EPA:EQS) Might Be Having Difficulty Using Its Capital Effectively

Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.05

Jun 10
Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.05

Pharmagest Interactive (EPA:PHA) Has Announced That It Will Be Increasing Its Dividend To €1.05

May 27
Pharmagest Interactive (EPA:PHA) Has Announced That It Will Be Increasing Its Dividend To €1.05

Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?

May 22
Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?

Here's What Pharmagest Interactive's (EPA:PHA) Strong Returns On Capital Mean

Apr 25
Here's What Pharmagest Interactive's (EPA:PHA) Strong Returns On Capital Mean

Are Investors Undervaluing Pharmagest Interactive SA (EPA:PHA) By 28%?

Feb 23
Are Investors Undervaluing Pharmagest Interactive SA (EPA:PHA) By 28%?

Here's Why I Think Pharmagest Interactive (EPA:PHA) Might Deserve Your Attention Today

Feb 09
Here's Why I Think Pharmagest Interactive (EPA:PHA) Might Deserve Your Attention Today

Is Pharmagest Interactive SA (EPA:PHA) Potentially Undervalued?

Jan 25
Is Pharmagest Interactive SA (EPA:PHA) Potentially Undervalued?

Many Would Be Envious Of Pharmagest Interactive's (EPA:PHA) Excellent Returns On Capital

Jan 06
Many Would Be Envious Of Pharmagest Interactive's (EPA:PHA) Excellent Returns On Capital

Pharmagest Interactive (EPA:PHA) Could Easily Take On More Debt

Nov 14
Pharmagest Interactive (EPA:PHA) Could Easily Take On More Debt

Is There An Opportunity With Pharmagest Interactive SA's (EPA:PHA) 20% Undervaluation?

Oct 30
Is There An Opportunity With Pharmagest Interactive SA's (EPA:PHA) 20% Undervaluation?

Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?

Sep 28
Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?

Is Pharmagest Interactive SA (EPA:PHA) Trading At A 20% Discount?

Jul 18
Is Pharmagest Interactive SA (EPA:PHA) Trading At A 20% Discount?

Pharmagest Interactive (EPA:PHA) Will Want To Turn Around Its Return Trends

Jun 24
Pharmagest Interactive (EPA:PHA) Will Want To Turn Around Its Return Trends

Does Pharmagest Interactive (EPA:PHA) Deserve A Spot On Your Watchlist?

Apr 08
Does Pharmagest Interactive (EPA:PHA) Deserve A Spot On Your Watchlist?

Pharmagest Interactive SA (EPA:PHA) Is An Attractive Dividend Stock - Here's Why

Mar 24
Pharmagest Interactive SA (EPA:PHA) Is An Attractive Dividend Stock - Here's Why

Pharmagest Interactive SA's (EPA:PHA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Mar 03
Pharmagest Interactive SA's (EPA:PHA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Our Take On The Returns On Capital At Pharmagest Interactive (EPA:PHA)

Feb 09
Our Take On The Returns On Capital At Pharmagest Interactive (EPA:PHA)

Shareholders of Pharmagest Interactive (EPA:PHA) Must Be Delighted With Their 500% Total Return

Jan 12
Shareholders of Pharmagest Interactive (EPA:PHA) Must Be Delighted With Their 500% Total Return

What To Know Before Buying Pharmagest Interactive SA (EPA:PHA) For Its Dividend

Dec 15
What To Know Before Buying Pharmagest Interactive SA (EPA:PHA) For Its Dividend

Rendimenti per gli azionisti

EQSFR Healthcare ServicesFR Mercato
7D-8.2%-4.3%-2.1%
1Y-28.3%-11.9%-2.1%

Ritorno vs Industria: EQS ha avuto una performance inferiore rispetto al French Healthcare Services che ha registrato un rendimento -11.9 % nell'ultimo anno.

Rendimento vs Mercato: EQS ha avuto una performance inferiore al mercato French che ha registrato un rendimento -2.1 % nell'ultimo anno.

Volatilità dei prezzi

Is EQS's price volatile compared to industry and market?
EQS volatility
EQS Average Weekly Movement5.0%
Healthcare Services Industry Average Movement5.9%
Market Average Movement4.5%
10% most volatile stocks in FR Market9.3%
10% least volatile stocks in FR Market2.3%

Prezzo delle azioni stabile: EQS non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 5% ) di EQS è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

FondatoI dipendentiAMMINISTRATORE DELEGATOSito web
19961,271Denis Supplissonequasens.com

Equasens Société anonyme fornisce soluzioni informatiche per la sanità in Europa. Offre id. PATIENT, un software aziendale; id.

Equasens Société anonyme Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Equasens Société anonyme con la sua capitalizzazione di mercato?
EQS statistiche fondamentali
Capitalizzazione di mercato€628.31m
Guadagni(TTM)€42.25m
Ricavi(TTM)€215.16m

14.9x

Rapporto P/E

2.9x

Rapporto P/S

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
EQS Conto economico (TTM)
Ricavi€215.16m
Costo del fatturato€151.30m
Profitto lordo€63.86m
Altre spese€21.60m
Guadagni€42.25m

Ultimi guadagni dichiarati

Jun 30, 2024

Prossima data di guadagno

n/a

Utile per azione (EPS)2.81
Margine lordo29.68%
Margine di profitto netto19.64%
Rapporto debito/patrimonio netto24.0%

Come si è comportato EQS nel lungo periodo?

Vedi performance storica e confronto

Dividendi

3.0%

Rendimento attuale del dividendo

45%

Rapporto di remunerazione